High titers of hemagglutination inhibition antibodies against 2009 H1N1 influenza virus in Southern Iran

Iranian Journal of Immunology

Volumn 7, Issue 1, 2010, Pages 39-48

  Moghadami, Mohsen ^a   Moattari, Afagh ^b   Tabatabaee, Hamid Reza ^c   Mirahmadizadeh, Alireza ^c   Rezaianzadeh, Abbas ^c   Hasanzadeh, Jafar ^c   Ebrahimi, Mostafa ^a   Zamiri, Nima ^a   Alborzi, Abdolvahab ^d   Lankarani, Kamran Bagheri ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Flu vaccine; H1N1; Hemagglutination inhibition; Humoral immunity

Indexed keywords

HEMAGGLUTINATION INHIBITING ANTIBODY; VIRUS ANTIBODY;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AGE; AGED; ANIMAL CELL; ANTIBODY TITER; ARTICLE; ASYMPTOMATIC INFECTION; CHILD; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FLU LIKE SYNDROME; HEMAGGLUTINATION INHIBITION TEST; HUMAN; HUMORAL IMMUNITY; INFANT; INFLUENZA VIRUS A H1N1; IRAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PILOT STUDY; PRESCHOOL CHILD; SCHOOL CHILD; SEROPREVALENCE; VIRUS IMMUNITY; BLOOD; CASE CONTROL STUDY; EPIDEMIC; EPIDEMIOLOGY; HEMAGGLUTINATION; IMMUNOLOGY; INFLUENZA;

ADULT; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; DISEASE OUTBREAKS; FEMALE; HEMAGGLUTINATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; IRAN; MALE; SEROEPIDEMIOLOGIC STUDIES;

EID: 77954743942     PISSN: 17351383     EISSN: 1735367X     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, et al. Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science. 2009; 325:197-201.
2. World Health Organization. Influenza-like illness in the United States and Mexico. WHO Epidemic and Pandemic Alert and Response. Available from: URL: http://www.who.int/csr/don/2009_04_24/en/index.html. Accessed April 27, 2009
3. Iranian ministry of health and medical education (MHME). weekly report of influenza. Available from: https://flu.behdasht.gov.ir/index.aspx?siteid=258&pageid=19072&newsview=8265. Accessed January 1, 2010
4. Centers for Disease Control and Prevention (CDC). Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep. 2009; 58:521-4.
5. Influenza A (H1N1): Special Highlights. World Health Organization. Available from: URL: www.who.int/csr/don/2009_07_06/en. Accessed October 1, 2009
6. Schmeisser F, Vodeiko GM, Lugovtsev VY, Stout RR, Weir JP. An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination. Vaccine. 2010; 28:2442-9.
7. Charlton B, Crossley B, Hiet S. et al. Conventional and future diagnostics for avian influenza. Comp Immunol Microbiol Infect Dis. 2009; 32:341-50.
8. Sturm-Ramirez KM, Ellis T, Bousfield B, Bissett L, Dyrting K, Rehg JE, et al. Reemerging H5N1 Influenza Viruses in Hong Kong in 2002 Are Highly Pathogenic to Ducks. J Virol. 2004; 78:4892-901.
9. Manuguerra JC, Hannoun C. Influenza and other viral respiratory diagnosis, surveillance and laboratory diagnosis. Paris Pasteur Institute. 1999; 286.
10. Suing GD. Hemagglutination inhibition test. Diagnostic Virology, New Haven and London. Yale university press 1973: 33.
11. Greenbaum JA, Kotturi MF, Kim Y, Oseroff C, Vaughan K, Salimi N, et al. Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci U S A. 2009; 106:20365-70.
12. Xing Z, Cardona CJ. Preexisting immunity to pandemic (H1N1). Emerg Infect Dis. 2009; 15:1847-9.
13. Chen H, Wang Y, Liu W, Zhang J, Dong B, Fan X, et al. Serologic survey of pandemic (H1N1) 2009 virus, Guangxi Province, China. Emerg Infect Dis. 2009; 15:1849-50.
14. Centers for Disease Control and Prevention (CDC). Serum cross reactive antibody response to a novel influenza A H1N1 virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep. 2009; 58:521-4.
15. Haghdoost MA, Gooya MM, Baneshi MR. Modeling of H1N1 flu in Iran. Arch Iran Med. 2009; 12:533-541.
16. WHO latest update on H1N1 influenza 2009. Update 83. Available from: URL: http://www.who.int/csr/don/2010_01_15/en/index.html
17. Gooya MM, Soroush M, Mokhtari-Azad T, Haghdoost AA, Hemati P, Moghadami M, et al. Influenza A(H1N1) pandemic in Iran: Report of first confirmed cases from June to November 2009. Arch Iran Med. 2010; 13:91-98.
18. Litchfield SM. Summary recommendation by the advisory committee on immunization practices (ACIP) for the use of H1N1 influenza vaccine foe the 2009-2010 vaccination season. AAOHN J. 2009; 57:354.
19. World Health Organization. WHO recommendations on pandemic (H1N1) 2009 vaccines. Available from: URL: http://www.who.int/csr/disease/swineflu/notes/h1n1_vaccine_20090713/en/print.html. Accessed September 16, 2009.
20. Couch RB. Seasonal inactivated influenza virus vaccines. Vaccine. 2008; 26:D5-9.
21. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, et al. Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus. N Eng J Med. 2009; 361:1945-52.
22. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, et al. In vitro and in vivo characterization of new swineorigin H1N1 influenza viruses. Nature. 2009; 460:1021-5.
23. Tumpey TM, García-Sastre A, Taubenberger JK, Palese P, Swayne DE, Basler CF. Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci U S A. 2004; 101:3166-71.
24. Chan YJ, Lee CL, Hwang SJ, Fung CP, Wang FD, Yen DH, et al. Seroprevalence of antibodies to pandemic (H1N1) 2009 influenza virus among hospital staff in a medical center in Taiwan. J Chin Med Assoc. 2010; 73:62-6.
25. Lum ME, McMillan AJ, Brook CW, Lester R, Piers LS. Impact of pandemic (H1N1) 2009 influenza on critical care capacity in Victoria. Med J Aust. 2009; 191:502-6.
26. Boni MF, Manh BH, Thai PQ, Farrar J, Hien TT, Hien NT, et al. Modeling the progression of pandemic influenza A (H1N1) in Vietnam and the opportunities for reassortment with other influenza viruses. BMC Med. 2009; 7:43.
27. Jain R, Goldman RD. Novel Influenza A (H1N1) Clinical Presentation, Diagnosis, and Management. Pediatr Emerg Care. 2009; 25:791-6.